As listed companies continue to release their share repurchase reports, the initial wave of fund portfolio adjustments for the new year has come to light. Notably, several funds overseen by esteemed managers like Feng Mingyuan, Dong Chen, Zhao Bei, and Zhou Weiwen have augmented their positions in Longli Technology, Arrow Home Products, Aohua Endoscopy, and Sanhua Intelligent Controls, respectively. These strategic shifts in their portfolios offer crucial market insights for investors.
